Votes & Verdicts

FTC BioPharma M&A Approach Clashes With Sector


Listen Later

The Federal Trade Commission’s approach to merger enforcement in the pharmaceutical and biotech industry has become increasingly aggressive. In this episode of the Votes and Verdicts podcast, Goodwin Procter’s Arman Oruc, co-chair of the company’s antitrust and competition practice, and Bloomberg Intelligence biotech analyst Marc Engelsgjerd join host and BI antitrust litigation analyst Jennifer Rie for a deeper and narrower dive of the FTC’s assessment of dealmaking and the impact on the biopharma sector.

See omnystudio.com/listener for privacy information.

...more
View all episodesView all episodes
Download on the App Store

Votes & VerdictsBy Bloomberg

  • 4
  • 4
  • 4
  • 4
  • 4

4

8 ratings


More shows like Votes & Verdicts

View all
WSJ What’s News by The Wall Street Journal

WSJ What’s News

4,374 Listeners

Bloomberg Intelligence by Bloomberg

Bloomberg Intelligence

403 Listeners

Odd Lots by Bloomberg

Odd Lots

1,983 Listeners

Bloomberg Law by Bloomberg

Bloomberg Law

383 Listeners

The a16z Show by Andreessen Horowitz

The a16z Show

1,091 Listeners

Trillions by Bloomberg

Trillions

195 Listeners

FT News Briefing by Financial Times

FT News Briefing

661 Listeners

RenMac by Jeff deGraaf, Neil Dutta, & Stephen Pavlick

RenMac

72 Listeners

Here's Why by Bloomberg

Here's Why

63 Listeners

The Big Take by Bloomberg

The Big Take

155 Listeners

Bloomberg Daybreak: US Edition by Bloomberg

Bloomberg Daybreak: US Edition

88 Listeners

Money Stuff: The Podcast by Bloomberg

Money Stuff: The Podcast

398 Listeners

Unhedged by Financial Times & Pushkin Industries

Unhedged

193 Listeners

Bloomberg Talks by Bloomberg

Bloomberg Talks

19 Listeners

The Real Eisman Playbook by Steve Eisman

The Real Eisman Playbook

200 Listeners